ConcertAI announced a multi-year agreement with Bayer to leverage ConcertAI's Translational360™ and AI SaaS solutions, which use artificial intelligence and machine learning (AI/ML)-derived insights ...

ConcertAI announced a multi-year agreement with Bayer to leverage ConcertAI's Translational360™ -- powered by Guardant Health liquid biopsy genomic data -- and AI SaaS solutions, which use artificial ...

Sol-Gel Technologies secures $16 million for clinical trials, advancing SGT-610 for ... Ltd. has announced a product purchase agreement with Mayne Pharma Group that will provide the company ...

As the awareness about the clinical trial is increasing the parties of the clinical trial agreement are becoming more critical about it. There are various types of contracts involved in clinical ...

today announced a development agreement to access blood samples from the multi-institutional, prospective, randomized Rete Italiana di Screening Polmonare (RISP) clinical trial. This study is ...

Clinical trials take a person out of that trusted environment, often in highly stressful health situations where a patient is already anxious and potentially confused or concerned. To get the best ...

There is no fee to register a study. Currently, you must register on clinicaltrials.gov if your study meets the FDAAA 801 definition of an "applicable clinical trial." While not always required, we ...

In this randomized double-blind controlled trial, the authors examine whether the combination of transcranial direct current stimulation and exposure–response prevention (ERP) is more effective ...

These fees are institution-wide and required for all sponsored studies conducted at KH. Effective 1/1/14: Medicare mandated that all clinical trial claims must contain the eight (8) digit clinical ...

In other recent news, Lixte Biotechnology Holdings, Inc. has amended a clinical trial agreement related to its lead compound, LB-100, relieving the company of approximately $3.095 million in ...

In other recent news, Lixte Biotechnology Holdings, Inc. has amended a clinical trial agreement related to its lead compound, LB-100, relieving the company of approximately $3.095 million in financial ...